Skip to main content
Geltrude Mingrone

Professor Geltrude Mingrone

Professor of Diabetes and Nutrition

Research interests

  • Diabetes
  • Nutrition

Biography

Professor Mingrone’s research mainly focus on the role of the small intestine in insulin resistance, type 2 diabetes and non-alcoholic fatty liver disease. She is expert in energy expenditure and metabolism regulation using indirect calorimetry and, in particular, the calorimetric chamber where a subject stays 24 hours in near free-living conditions. She studies body composition with MRI and DEXA. She investigates insulin sensitivity and fat metabolism with stable isotope infusion and euglycaemic hyperinsulinaemic clamp.

She received her MD and completed her residency in endocrinology and in gastroenterology at the Catholic University / Policlinico Gemelli in Rome, Italy. She obtained a PhD in Clinical Pharmacology at the University of Ghent in Belgium. Professor Mingrone received numerous awards, has given hundreds of presentations throughout the world, and is the author of over 350 articles in peer-reviewed journals and book chapters.

She contributed and is still contributing to the ADA/EASD guidelines for the treatment of type 2 diabetes.

    Research

    adipose fat cells
    Obesity, Type 2 Diabetes & Immunometabolism Research Group

    We are experimental medicine researchers and clinical academics. Our ‘bench to bedside’ research spans from basic discovery science, investigating the immune system and the susceptibility to obesity/insulin resistance, to an array of clinical studies investigating the impact of pharmacotherapy, bariatric surgery, diet and ethnicity on obesity and type 2 diabetes.

    News

    Incisionless device could revolutionise treatment for diabetes, liver disease and severe obesity

    A completely incisionless device that replicates metabolic surgery without making any cuts could surpass current technologies for managing metabolic...

    An obese man

    Surgery most effective treatment of metabolic liver disease

    Metabolic (bariatric) surgery is more effective than medications and lifestyle interventions for the treatment of advanced non-alcoholic fatty liver disease.

    surgery 780x440

    King's researchers create highly accurate non-invasive test for major liver diseases

    The liquid biopsy test, which uses two circulating proteins, was found to be highly accurate, sensitive, and specific for both NASH and liver fibrosis. For...

    blood test for NASH 780x450

    Gastrointestinal surgery can be a cure for type 2 diabetes finds new long-term study

    The results of a randomized clinical trial with the longest follow up to date show that metabolic surgery is more effective than medications and lifestyle...

    foreground shows surgical scissors, blurry background shows surgical team during operation

      Research

      adipose fat cells
      Obesity, Type 2 Diabetes & Immunometabolism Research Group

      We are experimental medicine researchers and clinical academics. Our ‘bench to bedside’ research spans from basic discovery science, investigating the immune system and the susceptibility to obesity/insulin resistance, to an array of clinical studies investigating the impact of pharmacotherapy, bariatric surgery, diet and ethnicity on obesity and type 2 diabetes.

      News

      Incisionless device could revolutionise treatment for diabetes, liver disease and severe obesity

      A completely incisionless device that replicates metabolic surgery without making any cuts could surpass current technologies for managing metabolic...

      An obese man

      Surgery most effective treatment of metabolic liver disease

      Metabolic (bariatric) surgery is more effective than medications and lifestyle interventions for the treatment of advanced non-alcoholic fatty liver disease.

      surgery 780x440

      King's researchers create highly accurate non-invasive test for major liver diseases

      The liquid biopsy test, which uses two circulating proteins, was found to be highly accurate, sensitive, and specific for both NASH and liver fibrosis. For...

      blood test for NASH 780x450

      Gastrointestinal surgery can be a cure for type 2 diabetes finds new long-term study

      The results of a randomized clinical trial with the longest follow up to date show that metabolic surgery is more effective than medications and lifestyle...

      foreground shows surgical scissors, blurry background shows surgical team during operation